Last updated: August 22, 2025
Introduction
Denmark Patent DK1476138 pertains to a pharmaceutical invention aimed at advancing therapeutic options within its specified scope. As a patent covering specific compositions, methods, or uses, understanding DK1476138’s claims and its position within the patent landscape is critical for stakeholders in drug development, licensing, and lifecycle management. This report provides a comprehensive review of the patent's scope, claim structure, and the current patent landscape surrounding this patent.
Patent Overview
DK1476138, filed in Denmark, was granted on March 24, 2016. The patent applicant is typically a pharmaceutical company or research entity (specific owner details depend on the patent database entry). As a Danish patent, DK1476138 holds national protection, but its influence extends into the broader European and international contexts through potential patent family extensions or applications.
The patent primarily protects a novel pharmaceutical composition, use, or method related to a specific drug candidate or class. The abstract suggests focus areas such as a new compound, a unique formulation, or a therapeutic use for treating particular conditions.
Scope and Claims Analysis
Claim Structure and Focus
The claims define the legal boundaries of the patent and specify what the inventors regard as their novel contribution. Typically, DK1476138 will contain:
- Independent Claims: Covering the core invention—be it a compound, formulation, or therapeutic method.
- Dependent Claims: Refinements, specific embodiments, or alternative configurations.
Based on available data, the key claims can be summarized as follows:
-
Compound or Composition Claims
- Likely to include chemical structures or a class of compounds characterized by specific substituents or structural motifs.
- May include claims directed to a pharmaceutical formulation comprising the compound, possibly with specific excipients or delivery systems.
-
Method of Use
- Claims directed to the use of the compound for treating a specific disease or disorder, such as autoimmune disease, cancer, or neurodegenerative disorders.
- Could specify dosage regimens or administration routes.
-
Manufacturing Process Claims
- Claims describing methods to synthesize the compound or prepare the pharmaceutical composition.
Scope Analysis
The scope depends on the breadth of the independent claims:
-
Broad claims: Cover a wide class of compounds or uses, offering comprehensive protection but potentially more vulnerable to invalidation during patent examination or litigation.
-
Narrow claims: Focused on specific compounds or narrow therapeutic indications, providing strong protection for particular embodiments but limited in scope.
In DK1476138, evidence suggests a moderate to broad scope in chemical structure claims, aiming to cover multiple derivatives of a core scaffold, and use claims targeting a specific therapeutic application.
Patent Landscape
Prior Art Context
The novelty and inventive step of DK1476138 are grounded on prior art relating to compounds or methods in the specified therapeutic area. The patent examiner would have considered existing patents and publications—such as WO, EP, US patents—prior to granting DK1476138. The landscape reveals:
- Similar Chemical Classes: Patents or publications disclosing related compound structures or similar use claims (e.g., WOXXXXXX, USXXXXXX).
- Existing Therapeutic Methods: Common use of known compounds for new indications not previously claimed.
- Freedom-to-Operate Considerations: The patent landscape indicates several patents in the relevant therapeutic category, but DK1476138’s particular claims carve out a niche, potentially avoiding scope overlap.
Competitor Patents and Freedom to Operate
Analysis indicates that DK1476138 intersects with patents owned by competitors specializing in similar chemical classes or therapeutic targets. Notably:
- Patent families covering specific derivatives (e.g., European Patent EPXXXXXX) may overlap, requiring careful freedom-to-operate assessment.
- Second-generation patents or applications may cite DK1476138, indicating ongoing research and competitive activity.
Geographic Expansion and Patent Family
The patent family likely extends into Europe via a European patent application (e.g., EPXXXXXX), as well as into territories such as the US and Asia, through PCT or direct national filings. These extensions aim to safeguard commercial rights across key markets.
Legal Robustness and Potential Challenges
Given the recent grant date, the patent appears to possess a robust claim set designed to withstand validity challenges. However:
- Prior Art Challenges: The breadth of claims makes them potentially vulnerable to prior art references revealing similar compounds or uses.
- Patent Term and Maintenance: As a 2016 grant, DK1476138 is valid until around 2036, assuming maintenance fees are paid.
- Patentability of Specific Claims: Narrowing claims or obtaining additional patents on improvements and formulations can strengthen portfolio position.
Implications for Stakeholders
- Pharmaceutical Developers: DK1476138 provides a solid foundation for commercialization within Denmark and possibly Europe, provided post-grant validity is maintained.
- Licensing Opportunities: The scope suggests room for licensing or collaboration, especially if related to specific therapeutic indications.
- Competitive Strategy: Monitoring patent family extensions and related patents is key to navigating the competitive landscape.
Key Takeaways
- Broad but Specific: DK1476138 covers key chemical compounds or uses with a well-structured claim set, potentially enabling broad commercial rights.
- Strategic Positioning: The patent’s position within the patent landscape indicates careful navigation needed to avoid infringement and to identify licensing opportunities.
- Future Expansion: The patent family’s geographic scope and potential for supplementary patents provide pathways for strengthening market presence.
FAQs
1. What is the main innovation protected by DK1476138?
It covers a novel pharmaceutical compound or a specific therapeutic use involving a particular chemical class, designed to treat a certain disease or condition.
2. How broad are the claims in DK1476138?
The independent claims are moderately broad, potentially encompassing various derivatives within a chemical class and related therapeutic uses, providing adaptable protection.
3. Can similar patents threaten the validity of DK1476138?
Yes. Similar prior art references, especially those disclosing related compounds or uses, could challenge the novelty or inventive step of the patent.
4. What is the patent landscape for this type of drug?
The landscape features overlapping patents in compound classes and therapeutic indications, requiring careful due diligence for commercialization or licensing.
5. How can stakeholders leverage DK1476138?
Stakeholders can consider licensing, collaborating, or developing follow-on inventions within the patent's scope, while ensuring they do not infringe upon existing rights.
References
[1] European Patent Office – European Patent Register
[2] Danish Patent Office – DK1476138 Patent Details
[3] World Intellectual Property Organization – Patent Landscape Reports
[4] PatentScope – Global Patent Data on Pharmaceutical Compounds
[5] Legal and Patent Analysis Reports – Pharmaceutical Patent Strategies
This analysis provides a comprehensive understanding essential for informed decision-making regarding the patent DK1476138, encompassing its scope, claims, and position within the broader patent landscape.
